When the mitral valve fails to close completely, blood flows backwards. From the left ventricle to the left atrium. During each heartbeat, this is mitral regurgitation. A valve disorder, its name refers to the mitral valve’s position. Between the left atrium and left ventricle. It’s one of four key valves controlling blood flow. Some people have mitral valve defects from birth. This causes the valve problem and leakage.
Epidemiology
Many older people have worn mitral valves that let blood flow backward. This often happens as folks age. It’s from mitral valve prolapse. It gets worse as people get older. Rheumatic heart disease isn’t common anymore in rich countries. But it’s still a big cause of bad mitral valves in places without good healthcare. Mitral valve prolapse often leads to the backflow problem. People in their 20s and 30s get diagnosed with it a lot. Both men and women can get mitral valve issues. But some studies show more women have mitral valve prolapse, which causes the backflow. In developed places, worn mitral valves are a top reason for the backward blood flow.
Anatomy
Pathophysiology
Mitral regurgitation is when blood flows backward from the left ventricle to the left atrium. This backflow causes the left ventricle to overfill with blood during each heartbeat. The excess blood volume in the left atrium leads to increased preload on the left ventricle during diastole. In chronic mitral regurgitation cases, the ventricle remodels itself to pump more blood. Initially, this remodeling raises the ejection fraction, though the amount varies. But as mitral regurgitation worsens, a cycle begins. The overfilled ventricle stretches, widening the mitral valve opening and reducing leaflet closure. This makes backflow even worse. Eventually, this cycle severely weakens the contraction and adds excessive workload on the ventricle. The ventricle then dilates more and pumps less forcefully over time, decreasing ejection fraction.
Etiology
Congenital: Sometimes, babies are born with unusual mitral valves. These include clefts, double openings, and parachute-shaped valves. While rare, these are known to cause mitral regurgitation (MR). Studies confirm these conditions lead to MR.
Infectious: Rheumatic heart disease affects over 15 million globally, mainly in developing countries. Lack of medical care and vaccines let it spread. This inflammation of the heart often scars the mitral valve, allowing blood to flow backward (regurgitate).
Degenerative: Mitral valve prolapse is the main cause of degenerative MR. The valve’s tissue degenerates over time. Sometimes it’s the primary issue, worsening with age. Other times, connective tissue disorders like Marfan syndrome are the culprit. Ultimately, the prolapsed valve can’t close properly, permitting regurgitation.
Genetics
Prognostic Factors
Mild mitral regurgitation often has a positive prospect. Minimal backflow of blood occurs. As the condition worsens, timely diagnosis and correct therapy become crucial for a favorable outcome. The severity of MR dictates the prognosis increasingly.
Clinical History
When listening with a stethoscope, doctors hear a distinct sound, called a “holosystolic” murmur. The murmur is loudest at the heart’s tip. People with MR often feel tired and low on energy. This happens because their heart has to work harder. Breathlessness is common, especially during exercise or lying down. Their heart struggles to pump blood well. Coughing a lot, especially at night or lying down, can occur. Blood flows back into the lungs, causing congestion. If MR develops slowly, the body adjusts. But sudden, severe MR causes worse symptoms quickly.
Physical Examination
When checking for mitral regurgitation (MR), listen carefully. The MR murmur may sound louder near the left chest and lower breastbone. Very severe cases may have an extra heart sound, called an S3 gallop, showing too much blood pumping out. A key sign is a murmur that lasts all through when the heart pumps out blood. It’s often loudest near the heart’s tip and may be heard under the arm too. Other signs include the heart’s pumping spot seeming pushed out to the side and beating harder if MR has lasted a long time. You may also hear crackling lung sounds from fluid buildup, or swelling in the legs or feet, showing heart failure, especially with long-lasting MR. How noticeable these signs are depends on how severe the MR is and how long it has been going on, with sudden MR causing more obvious and quickly worsening symptoms.
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Cardiac tamponade
Acute coronary syndrome
Septic shock
Congestive heart failure exacerbation
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
The management of mitral regurgitation (MR) involves a broad approach. This aims to control symptoms, prevent disease worsening, and improve overall outlook. ACE inhibitors and ARBs were studied for asymptomatic MR. But their effectiveness is uncertain. Their routine use is not strongly advised due to limited proof. Beta-blockers may not help much in primary MR, though. In secondary MR, they might aid survival – like carvedilol, per studies. But ACC lacks specific guidelines for beta-blockers in MR. Medical therapy usually involves loop diuretics. They may ease symptoms and lower afterload and regurgitant volume. But more research is needed to confirm their efficacy. Surgery – mitral valve repair or replacement – is needed in severe cases or if symptoms persist despite medicines. Factors like cause, tissue damage extent, and patient factors guide decisions. Treatment should be personalized, using a team-based approach and regular monitoring to optimize patient results.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
The choice to pursue surgery depends on the MR’s root cause. Patients with damage from broken chords/muscles or infected valves often need MR surgery. When ischemia causes functional MR, a bypass may be required. The AHA usually suggests valve repair over replacement to reduce MR recurrence. But, extensive damage from infection might need full replacement. Mechanical valves last longer but both need blood thinners after surgery. For high-risk patients who can’t have surgery, MitraClip provides a less invasive option. Tailored treatment plans are key based on each person’s specific needs.
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Angiotensin-converting enzyme inhibitors
Angiotensin-converting enzyme inhibitors
A group of medicines, ACEIs and ARBs, were seen as possible ways to slow down the worsening of mitral regurgitation (MR) in patients without symptoms. These drugs were thought to reduce the amount of blood going backward and the size of the left ventricle. But there is little proof that they actually help with MR. Using them for MR is not recommended. Some studies looking at their benefits did not find clear answers. In fact, certain studies showed that these medicines may even make MR worse for some patients. Furthermore, in conditions like hypertrophic cardiomyopathy or mitral valve prolapse, using vasodilators has been linked to increased MR severity. This highlights how important it is to carefully consider each patient’s specific heart condition when prescribing medicines for managing MR.
Beta-blockers
Beta-blockers are prescription drugs that slow the heart rate. Some researchers studied if they help treat mitral regurgitation (MR). This is a heart valve disorder where blood leaks backward. Beta-blockers did not seem helpful for basic MR. But a few studies showed they extended life in secondary MR. One study on carvedilol found it preserved heart function and reduced backflow. However, heart doctor groups did not recommend beta-blockers specifically for MR yet. Loop diuretics are “water pills” that make you urinate more. Doctors think combining them with drugs that lower backflow might benefit MR. Although the proof is not solid yet; more research is needed.
When the mitral valve fails to close completely, blood flows backwards. From the left ventricle to the left atrium. During each heartbeat, this is mitral regurgitation. A valve disorder, its name refers to the mitral valve’s position. Between the left atrium and left ventricle. It’s one of four key valves controlling blood flow. Some people have mitral valve defects from birth. This causes the valve problem and leakage.
Many older people have worn mitral valves that let blood flow backward. This often happens as folks age. It’s from mitral valve prolapse. It gets worse as people get older. Rheumatic heart disease isn’t common anymore in rich countries. But it’s still a big cause of bad mitral valves in places without good healthcare. Mitral valve prolapse often leads to the backflow problem. People in their 20s and 30s get diagnosed with it a lot. Both men and women can get mitral valve issues. But some studies show more women have mitral valve prolapse, which causes the backflow. In developed places, worn mitral valves are a top reason for the backward blood flow.
Mitral regurgitation is when blood flows backward from the left ventricle to the left atrium. This backflow causes the left ventricle to overfill with blood during each heartbeat. The excess blood volume in the left atrium leads to increased preload on the left ventricle during diastole. In chronic mitral regurgitation cases, the ventricle remodels itself to pump more blood. Initially, this remodeling raises the ejection fraction, though the amount varies. But as mitral regurgitation worsens, a cycle begins. The overfilled ventricle stretches, widening the mitral valve opening and reducing leaflet closure. This makes backflow even worse. Eventually, this cycle severely weakens the contraction and adds excessive workload on the ventricle. The ventricle then dilates more and pumps less forcefully over time, decreasing ejection fraction.
Congenital: Sometimes, babies are born with unusual mitral valves. These include clefts, double openings, and parachute-shaped valves. While rare, these are known to cause mitral regurgitation (MR). Studies confirm these conditions lead to MR.
Infectious: Rheumatic heart disease affects over 15 million globally, mainly in developing countries. Lack of medical care and vaccines let it spread. This inflammation of the heart often scars the mitral valve, allowing blood to flow backward (regurgitate).
Degenerative: Mitral valve prolapse is the main cause of degenerative MR. The valve’s tissue degenerates over time. Sometimes it’s the primary issue, worsening with age. Other times, connective tissue disorders like Marfan syndrome are the culprit. Ultimately, the prolapsed valve can’t close properly, permitting regurgitation.
Mild mitral regurgitation often has a positive prospect. Minimal backflow of blood occurs. As the condition worsens, timely diagnosis and correct therapy become crucial for a favorable outcome. The severity of MR dictates the prognosis increasingly.
When listening with a stethoscope, doctors hear a distinct sound, called a “holosystolic” murmur. The murmur is loudest at the heart’s tip. People with MR often feel tired and low on energy. This happens because their heart has to work harder. Breathlessness is common, especially during exercise or lying down. Their heart struggles to pump blood well. Coughing a lot, especially at night or lying down, can occur. Blood flows back into the lungs, causing congestion. If MR develops slowly, the body adjusts. But sudden, severe MR causes worse symptoms quickly.
When checking for mitral regurgitation (MR), listen carefully. The MR murmur may sound louder near the left chest and lower breastbone. Very severe cases may have an extra heart sound, called an S3 gallop, showing too much blood pumping out. A key sign is a murmur that lasts all through when the heart pumps out blood. It’s often loudest near the heart’s tip and may be heard under the arm too. Other signs include the heart’s pumping spot seeming pushed out to the side and beating harder if MR has lasted a long time. You may also hear crackling lung sounds from fluid buildup, or swelling in the legs or feet, showing heart failure, especially with long-lasting MR. How noticeable these signs are depends on how severe the MR is and how long it has been going on, with sudden MR causing more obvious and quickly worsening symptoms.
Cardiac tamponade
Acute coronary syndrome
Septic shock
Congestive heart failure exacerbation
The management of mitral regurgitation (MR) involves a broad approach. This aims to control symptoms, prevent disease worsening, and improve overall outlook. ACE inhibitors and ARBs were studied for asymptomatic MR. But their effectiveness is uncertain. Their routine use is not strongly advised due to limited proof. Beta-blockers may not help much in primary MR, though. In secondary MR, they might aid survival – like carvedilol, per studies. But ACC lacks specific guidelines for beta-blockers in MR. Medical therapy usually involves loop diuretics. They may ease symptoms and lower afterload and regurgitant volume. But more research is needed to confirm their efficacy. Surgery – mitral valve repair or replacement – is needed in severe cases or if symptoms persist despite medicines. Factors like cause, tissue damage extent, and patient factors guide decisions. Treatment should be personalized, using a team-based approach and regular monitoring to optimize patient results.
The choice to pursue surgery depends on the MR’s root cause. Patients with damage from broken chords/muscles or infected valves often need MR surgery. When ischemia causes functional MR, a bypass may be required. The AHA usually suggests valve repair over replacement to reduce MR recurrence. But, extensive damage from infection might need full replacement. Mechanical valves last longer but both need blood thinners after surgery. For high-risk patients who can’t have surgery, MitraClip provides a less invasive option. Tailored treatment plans are key based on each person’s specific needs.
Cardiology, General
Angiotensin-converting enzyme inhibitors
A group of medicines, ACEIs and ARBs, were seen as possible ways to slow down the worsening of mitral regurgitation (MR) in patients without symptoms. These drugs were thought to reduce the amount of blood going backward and the size of the left ventricle. But there is little proof that they actually help with MR. Using them for MR is not recommended. Some studies looking at their benefits did not find clear answers. In fact, certain studies showed that these medicines may even make MR worse for some patients. Furthermore, in conditions like hypertrophic cardiomyopathy or mitral valve prolapse, using vasodilators has been linked to increased MR severity. This highlights how important it is to carefully consider each patient’s specific heart condition when prescribing medicines for managing MR.
Beta-blockers
Beta-blockers are prescription drugs that slow the heart rate. Some researchers studied if they help treat mitral regurgitation (MR). This is a heart valve disorder where blood leaks backward. Beta-blockers did not seem helpful for basic MR. But a few studies showed they extended life in secondary MR. One study on carvedilol found it preserved heart function and reduced backflow. However, heart doctor groups did not recommend beta-blockers specifically for MR yet. Loop diuretics are “water pills” that make you urinate more. Doctors think combining them with drugs that lower backflow might benefit MR. Although the proof is not solid yet; more research is needed.
medtigo
Mitral regurgitation
Updated :
April 10, 2024
When the mitral valve fails to close completely, blood flows backwards. From the left ventricle to the left atrium. During each heartbeat, this is mitral regurgitation. A valve disorder, its name refers to the mitral valve’s position. Between the left atrium and left ventricle. It’s one of four key valves controlling blood flow. Some people have mitral valve defects from birth. This causes the valve problem and leakage.
Many older people have worn mitral valves that let blood flow backward. This often happens as folks age. It’s from mitral valve prolapse. It gets worse as people get older. Rheumatic heart disease isn’t common anymore in rich countries. But it’s still a big cause of bad mitral valves in places without good healthcare. Mitral valve prolapse often leads to the backflow problem. People in their 20s and 30s get diagnosed with it a lot. Both men and women can get mitral valve issues. But some studies show more women have mitral valve prolapse, which causes the backflow. In developed places, worn mitral valves are a top reason for the backward blood flow.
Mitral regurgitation is when blood flows backward from the left ventricle to the left atrium. This backflow causes the left ventricle to overfill with blood during each heartbeat. The excess blood volume in the left atrium leads to increased preload on the left ventricle during diastole. In chronic mitral regurgitation cases, the ventricle remodels itself to pump more blood. Initially, this remodeling raises the ejection fraction, though the amount varies. But as mitral regurgitation worsens, a cycle begins. The overfilled ventricle stretches, widening the mitral valve opening and reducing leaflet closure. This makes backflow even worse. Eventually, this cycle severely weakens the contraction and adds excessive workload on the ventricle. The ventricle then dilates more and pumps less forcefully over time, decreasing ejection fraction.
Congenital: Sometimes, babies are born with unusual mitral valves. These include clefts, double openings, and parachute-shaped valves. While rare, these are known to cause mitral regurgitation (MR). Studies confirm these conditions lead to MR.
Infectious: Rheumatic heart disease affects over 15 million globally, mainly in developing countries. Lack of medical care and vaccines let it spread. This inflammation of the heart often scars the mitral valve, allowing blood to flow backward (regurgitate).
Degenerative: Mitral valve prolapse is the main cause of degenerative MR. The valve’s tissue degenerates over time. Sometimes it’s the primary issue, worsening with age. Other times, connective tissue disorders like Marfan syndrome are the culprit. Ultimately, the prolapsed valve can’t close properly, permitting regurgitation.
Mild mitral regurgitation often has a positive prospect. Minimal backflow of blood occurs. As the condition worsens, timely diagnosis and correct therapy become crucial for a favorable outcome. The severity of MR dictates the prognosis increasingly.
When listening with a stethoscope, doctors hear a distinct sound, called a “holosystolic” murmur. The murmur is loudest at the heart’s tip. People with MR often feel tired and low on energy. This happens because their heart has to work harder. Breathlessness is common, especially during exercise or lying down. Their heart struggles to pump blood well. Coughing a lot, especially at night or lying down, can occur. Blood flows back into the lungs, causing congestion. If MR develops slowly, the body adjusts. But sudden, severe MR causes worse symptoms quickly.
When checking for mitral regurgitation (MR), listen carefully. The MR murmur may sound louder near the left chest and lower breastbone. Very severe cases may have an extra heart sound, called an S3 gallop, showing too much blood pumping out. A key sign is a murmur that lasts all through when the heart pumps out blood. It’s often loudest near the heart’s tip and may be heard under the arm too. Other signs include the heart’s pumping spot seeming pushed out to the side and beating harder if MR has lasted a long time. You may also hear crackling lung sounds from fluid buildup, or swelling in the legs or feet, showing heart failure, especially with long-lasting MR. How noticeable these signs are depends on how severe the MR is and how long it has been going on, with sudden MR causing more obvious and quickly worsening symptoms.
Cardiac tamponade
Acute coronary syndrome
Septic shock
Congestive heart failure exacerbation
The management of mitral regurgitation (MR) involves a broad approach. This aims to control symptoms, prevent disease worsening, and improve overall outlook. ACE inhibitors and ARBs were studied for asymptomatic MR. But their effectiveness is uncertain. Their routine use is not strongly advised due to limited proof. Beta-blockers may not help much in primary MR, though. In secondary MR, they might aid survival – like carvedilol, per studies. But ACC lacks specific guidelines for beta-blockers in MR. Medical therapy usually involves loop diuretics. They may ease symptoms and lower afterload and regurgitant volume. But more research is needed to confirm their efficacy. Surgery – mitral valve repair or replacement – is needed in severe cases or if symptoms persist despite medicines. Factors like cause, tissue damage extent, and patient factors guide decisions. Treatment should be personalized, using a team-based approach and regular monitoring to optimize patient results.
The choice to pursue surgery depends on the MR’s root cause. Patients with damage from broken chords/muscles or infected valves often need MR surgery. When ischemia causes functional MR, a bypass may be required. The AHA usually suggests valve repair over replacement to reduce MR recurrence. But, extensive damage from infection might need full replacement. Mechanical valves last longer but both need blood thinners after surgery. For high-risk patients who can’t have surgery, MitraClip provides a less invasive option. Tailored treatment plans are key based on each person’s specific needs.
Cardiology, General
Angiotensin-converting enzyme inhibitors
A group of medicines, ACEIs and ARBs, were seen as possible ways to slow down the worsening of mitral regurgitation (MR) in patients without symptoms. These drugs were thought to reduce the amount of blood going backward and the size of the left ventricle. But there is little proof that they actually help with MR. Using them for MR is not recommended. Some studies looking at their benefits did not find clear answers. In fact, certain studies showed that these medicines may even make MR worse for some patients. Furthermore, in conditions like hypertrophic cardiomyopathy or mitral valve prolapse, using vasodilators has been linked to increased MR severity. This highlights how important it is to carefully consider each patient’s specific heart condition when prescribing medicines for managing MR.
Beta-blockers
Beta-blockers are prescription drugs that slow the heart rate. Some researchers studied if they help treat mitral regurgitation (MR). This is a heart valve disorder where blood leaks backward. Beta-blockers did not seem helpful for basic MR. But a few studies showed they extended life in secondary MR. One study on carvedilol found it preserved heart function and reduced backflow. However, heart doctor groups did not recommend beta-blockers specifically for MR yet. Loop diuretics are “water pills” that make you urinate more. Doctors think combining them with drugs that lower backflow might benefit MR. Although the proof is not solid yet; more research is needed.
Loading...
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
